Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society 2023 Annual Global Meeting
AADI Stock | USD 2.34 0.06 2.63% |
Under 57% of all Aadi Bioscience's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that some traders are interested. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
Aadi |
Aadi Bioscience, Inc. , a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway alterations, today announced e-poster presentations at the International Gynecologic Cancer Society 2023 Annual Global Meeting, taking place November 5-7, 2023, in Seoul, Korea.
Read at finance.yahoo.com
Aadi Bioscience Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Aadi Bioscience Fundamental Analysis
We analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Aadi Bioscience is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Aadi Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aadi Bioscience stock to make a market-neutral strategy. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics with similar companies.
Peers
Aadi Bioscience Related Equities
ANTX | AN2 Therapeutics | 21.90 | ||||
GLUE | Monte Rosa | 13.72 | ||||
ARVN | Arvinas | 2.85 | ||||
ADAG | Adagene | 1.30 | ||||
RZLT | Rezolute | 1.00 | ||||
ACRV | Acrivon Therapeutics, | 0.80 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
DSGN | Design Therapeutics | 0.50 | ||||
AVTE | Aerovate Therapeutics | 0.38 | ||||
ANAB | AnaptysBio | 0.64 | ||||
CRNX | Crinetics Pharmaceuticals | 0.81 | ||||
RARE | Ultragenyx | 1.04 | ||||
KURA | Kura Oncology | 1.16 | ||||
RVMD | Revolution Medicines | 1.25 | ||||
ERAS | Erasca | 2.05 | ||||
MLYS | Mineralys Therapeutics, | 2.59 |
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |